Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8411100 | Drug Discovery Today: Disease Models | 2011 | 5 Pages |
Abstract
Disseminated tumor cells (DTCs) are considered to be the potential metastasis initiating cells. Elucidating the biology of DTCs promises a better understanding of metastasis and might enable more effective therapies to tackle metastasis. Unfortunately, DTCs are very difficult to trace in cancer patients constraining their comprehensive biologic characterization. Therefore, non-human in vivo models are needed to replicate the complex metastatic cascade to study DTCs in a realistic context. On the basis of two recently published models, we argue here that currently only transgenic mouse cancer models permit such studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
B. Möhlendick, D. Niederacher, N.H. Stoecklein,